152 related articles for article (PubMed ID: 18214759)
21. Influence of plasticizer type and level on the properties of Eudragit S100 matrix pellets prepared by hot-melt extrusion.
Schilling SU; Lirola HL; Shah NH; Waseem Malick A; McGinity JW
J Microencapsul; 2010; 27(6):521-32. PubMed ID: 20575612
[TBL] [Abstract][Full Text] [Related]
22. Accelerated ketoprofen release from polymeric matrices: importance of the homogeneity/heterogeneity of excipient distribution.
Gue E; Willart JF; Muschert S; Danede F; Delcourt E; Descamps M; Siepmann J
Int J Pharm; 2013 Nov; 457(1):298-307. PubMed ID: 24076398
[TBL] [Abstract][Full Text] [Related]
23. The preparation and evaluation of sustained release suppositories containing ketoprofen and Eudragit RL 100 by using factorial design.
Ozgüney I; Ozcan I; Ertan G; Güneri T
Pharm Dev Technol; 2007; 12(1):97-107. PubMed ID: 17484149
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo evaluations of ketoprofen extended release pellets prepared using powder layering technique in a rotary centrifugal granulator.
Pai R; Kohli K; Jain G; Srivastava B
Arch Pharm Res; 2011 Jul; 34(7):1135-42. PubMed ID: 21811920
[TBL] [Abstract][Full Text] [Related]
25. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
26. Development and evaluation of controlled release ibuprofen matrix tablets by direct compression technique.
Patel N; Madan P; Lin S
Pharm Dev Technol; 2011 Feb; 16(1):1-11. PubMed ID: 20491616
[TBL] [Abstract][Full Text] [Related]
27. Microencapsulation of semisolid ketoprofen/polymer microspheres.
Palmieri G; Bonacucina G; Di Martino P; Martelli S
Int J Pharm; 2002 Aug; 242(1-2):175-8. PubMed ID: 12176242
[TBL] [Abstract][Full Text] [Related]
28. Chronotherapeutic Drug Delivery of Ketoprofen and Ibuprofen for Improved Treatment of Early Morning Stiffness in Arthritis Using Hot-Melt Extrusion Technology.
Dumpa NR; Sarabu S; Bandari S; Zhang F; Repka MA
AAPS PharmSciTech; 2018 Aug; 19(6):2700-2709. PubMed ID: 29968041
[TBL] [Abstract][Full Text] [Related]
29. Stereoselective drug release from ketoprofen and ricobendazole matrix tablets.
Alvarez C; Torrado JJ; Cadórniga R
Chirality; 1999; 11(8):611-5. PubMed ID: 10467311
[TBL] [Abstract][Full Text] [Related]
30. Mechanical properties and drug release of venlafaxine HCl solid mini matrices prepared by hot-melt extrusion and hot or ambient compression.
Avgerinos T; Kantiranis N; Panagopoulou A; Malamataris S; Kachrimanis K; Nikolakakis I
Drug Dev Ind Pharm; 2018 Feb; 44(2):338-348. PubMed ID: 29023145
[TBL] [Abstract][Full Text] [Related]
31. Properties of hot-melt extruded tablet formulations for the colonic delivery of 5-aminosalicylic acid.
Bruce LD; Shah NH; Malick AW; Infeld MH; McGinity JW
Eur J Pharm Biopharm; 2005 Jan; 59(1):85-97. PubMed ID: 15567305
[TBL] [Abstract][Full Text] [Related]
32. Influence of sulfobutyl ether beta-cyclodextrin (Captisol) on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion.
Fukuda M; Miller DA; Peppas NA; McGinity JW
Int J Pharm; 2008 Feb; 350(1-2):188-96. PubMed ID: 17920217
[TBL] [Abstract][Full Text] [Related]
33. Compressed biodegradable matrices of spray-dried PLGA microspheres for the modified release of ketoprofen.
Gavini E; Sanna V; Juliano C; Giunchedi P
J Microencapsul; 2003; 20(2):193-201. PubMed ID: 12554374
[TBL] [Abstract][Full Text] [Related]
34. [Preparation of pantoprazole sodium enteric-coated pellets-type tablets].
Chen MM; Wang CR; Jin Y
Yao Xue Xue Bao; 2011 Jan; 46(1):96-101. PubMed ID: 21465814
[TBL] [Abstract][Full Text] [Related]
35. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
[TBL] [Abstract][Full Text] [Related]
36. KINETICS STUDY ON KETOPROFEN RELEASE FROM MINI TABLETS AND MULTI-COMPARTMENT SYSTEMS.
Stawarski T; Sieradzki E; Gałecka E; Binek K
Acta Pol Pharm; 2016; 73(3):731-7. PubMed ID: 27476291
[TBL] [Abstract][Full Text] [Related]
37. Chitosan and enteric polymer based once daily sustained release tablets of aceclofenac: in vitro and in vivo studies.
Mutalik S; Manoj K; Reddy MS; Kushtagi P; Usha AN; Anju P; Ranjith AK; Udupa N
AAPS PharmSciTech; 2008; 9(2):651-9. PubMed ID: 18500561
[TBL] [Abstract][Full Text] [Related]
38. Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug delivery.
Moustafine RI; Margulis EB; Sibgatullina LF; Kemenova VA; Van den Mooter G
Eur J Pharm Biopharm; 2008 Sep; 70(1):215-25. PubMed ID: 18691856
[TBL] [Abstract][Full Text] [Related]
39. Alginate-magnesium aluminum silicate films: effect of plasticizers on film properties, drug permeation and drug release from coated tablets.
Pongjanyakul T; Puttipipatkhachorn S
Int J Pharm; 2007 Mar; 333(1-2):34-44. PubMed ID: 17056214
[TBL] [Abstract][Full Text] [Related]
40. Release of ketoprofen enantiomers from HPMC K100M matrices--diffusion studies.
Solinís MA; de la Cruz Y; Hernández RM; Gascón AR; Calvo B; Pedraz JL
Int J Pharm; 2002 Jun; 239(1-2):61-8. PubMed ID: 12052691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
